Innate immune cells recruited to inflammatory sites have short life spans and originate from the marrow, which is distributed throughout the long and flat bones. While bone marrow production and release of leukocyte increases after stroke, it is currently unknown whether its activity rises homogeneously throughout the entire hematopoietic system. To address this question, we employed spectrally resolved in vivo cell labeling in the murine skull and tibia. We show that in murine models of stroke and aseptic meningitis, skull bone marrow-derived neutrophils are more likely to migrate to the adjacent brain tissue than cells that reside in the tibia. Confocal microscopy of the skull-dura interface revealed myeloid cell migration through microscopic vascular channels crossing the inner skull cortex. These observations point to a direct local interaction between the brain and the skull bone marrow through the meninges.
I nflammation is an essential defense and repair mechanism that is tightly orchestrated in many human diseases. The hematopoietic system supplies most cellular components of sterile inflammation. The abundance of circulating innate immune cells correlates closely with mortality 1 and fluctuates dramatically after ischemic injury or systemic infection [2] [3] [4] [5] . Once recruited to sites of inflammation, neutrophils and other immune cells may defend against infection, but they also have destructive properties. This often contributes to tissue damage and impaired organ function. Specifically, ischemic brain recruits myeloid cells 2, 4, 6 after activating the bone marrow via the sympathetic nervous system 7 . Given the short life span of myeloid cells in blood and in inflamed tissues, the marrow's supply of these cells influences systemic and local inflammatory activity. Bone marrow is therefore increasingly becoming an organ of therapeutic interest in inflammatory diseases.
On a microscopic scale, functional marrow heterogeneity is being studied intensively, leading to several emerging niche concepts 8 . Quiescent blood stem cells are thought to reside close to osteoblasts and arterioles, while proliferating hematopoietic progenitors are located near sinusoids, which are also discussed as a site from where leukocytes are released from marrow into systemic circulation 9 . Beyond the distinction between red versus yellow marrow, much less is known about the macroscopic heterogeneity of the bone marrow. On the one hand, this relative paucity of data is unexpected, given that this organ system literally spans from head to toe and that there are many different types of long and flat bones. On the other hand, studying such a large and widespread organ is challenging, given that cellular resolution is often required to understand the marrow's function, in particular cell migration. In vivo sampling in humans relies on bone marrow biopsies, which are limited to one site only, mostly the iliac crest.
To begin addressing the knowledge gap on the marrow's functional heterogeneity, we developed a localized cell-tagging approach to label bone marrow cells residing in the mouse skull and tibia with spectrally resolved membrane dyes that serve as cell trackers. This allowed us to determine the origin of leukocytes that were recruited to inflamed tissues after being labeled in the bone marrow. We found that in ischemic and chemically induced models of acute cerebral inflammation, skull bone marrow contributed more neutrophils than tibial marrow. Using an organ-bath microscopy setup to image the inner surface of the mouse skull, we found that neutrophils take an unexpected 'shortcut': myeloid cells migrate toward the inflamed brain through microscopic channels that cross the inner skull cortex and thus directly connect the skull marrow cavities with the dura.
Results
Spectrally resolved site-specific cell tagging. We began by testing two commercially available cell-permeant fluorescent dyes with different excitation and emission spectra, FITC and APC, for their celllabeling efficiency. Cells separately incubated with the dyes in vitro demonstrated excellent concentration-dependent labeling, which was readily detected by flow cytometry in the respective APC and FITC channels (Fig. 1a ). Selective bone marrow microinjection of 3-10 µ L cell tracker was then performed in vivo using a Hamilton syringe equipped with a custom 34-gauge blunt needle. Based on the observed in vitro labeling efficiencies, we chose a cell tracker dose for in situ bone marrow labeling that created a steep fluorescence gradient between the marrow compartment and the systemic circulation. Twenty-four hours after microinjections into the skull and the tibia, we examined the labeling efficiency for neutrophils harvested from the injection and remote control sites, specifically the spleen and blood. We focused on neutrophils because these cells are numerous first responders to tissue injury. Labeled neutrophils were readily detected at sites of injection by flow cytometry (Fig. 1b ). Low numbers of labeled cells were also detected in the blood and spleen (Fig. 1b) . Cell exposure to locally concentrated dye after injection into the marrow yielded high cell-associated fluorescence intensities (Fig. 1b) , whereas intravenously injected dye, which resembles cell-unassociated dye leaking into the circulation after marrow injection, was so diluted that we did not detect any labeled cells (Fig. 1c ).
Confocal microscopy of the skull (Fig. 1d ) and the tibia (Fig. 1e ) following cell tracker injection showed locally contained fluorescence and efficient cell labeling. While dye microinjections slightly decreased cell viability, this occurred to the same extent in both compartments and did not alter marrow cell content or migration of cells to the inflamed brain after stroke ( Supplementary Fig. 1a,b ). Following skull injections, we used microglia, which are not bone marrow-derived, as 'witness cells' to explore whether skull marrow labeling is locally contained or spills over in inflammatory brain conditions. Microglial cells were only APC + when red cell tracker was purposely injected through the skull below the dura, but not after injection into the marrow ( Supplementary Fig. 1c,d ). Taken together, these data demonstrate that intramarrow cell-tracker injections label cells in the skull and tibia with an efficiency sufficient for systemic cell tracking by flow cytometry.
Tracking cell origins in different inflammatory sites. We next used the cell-tracking approach to determine relative neutrophil sources in several models of acute inflammation, including ischemic stroke, acute myocardial infarction, and inflammation induced by intracisternal carrageenan injection, which leads to aseptic meningoencephalitis 10 ( Fig. 2 ). To explore neutrophil contributions to inflammatory sites, we first injected red and green cell trackers into the skull and tibia, respectively. Destination tissues were then processed and stained with an antibody cocktail for flow-cytometry detection of cell surface markers, reserving two channels for the spectrally resolved cell trackers. Flow cytometry gates were positioned based on intravenously injected control animals ( Supplementary Fig. 2 ). We focused on neutrophil migration during early inflammation and normalized labeled-cell frequencies in tissues of interest to the labeling efficiency at the site of origin ( Fig. 2a-e ). We found that the skull contributed significantly more neutrophils to the ischemic brain hemisphere than the tibia (Fig. 2a ). The frequency of cells originating from the skull or the tibia was not significantly different in the spleen and the blood, with the exception of the spleen 2 d after stroke, which showed a decreased contribution of cells from the tibia (Fig. 2b,c) . Raw frequencies and ratios to blood are provided in Supplementary Fig. 3 . Like ischemic stroke, intracisternal injection of carrageenan, leading to meningoencephalitis 10 , also elicited a higher contribution of skull neutrophils to brain inflammation ( Fig. 2d ). In contrast, 1 d after myocardial infarction, the neutrophil contributions of the skull and the tibia, which are both distant from the heart, were comparable ( Fig. 2e ), indicating that the proximity of brain inflammation to skull bone marrow may influence cell migration paths. We next used ex vivo confocal microscopy of the fresh brain after in vivo staining of the vasculature to explore the location of cells tagged in skull or tibia after induction of meningoencephalitis. We primarily found cells originating from the skull (8 of 12 tagged cells), which were located in the brain parenchyma, outside of the vasculature ( Supplementary Fig. 4 ). The observation of preferential skull neutrophil recruitment to the brain was not caused by the size of the labeled marrow compartment, as the cellularity of one tibia roughly equaled that of the skull (Fig. 2f ).
Myeloid cell population dynamics depend on marrow location.
To explore whether the observed migration heterogeneity causes differences in the marrow's myeloid cell numbers, we enumerated neutrophils and monocytes in the skull and tibia at different timepoints after stroke. Compared to sham controls, stroke led to a significant decrease of neutrophils and monocytes in the skull bone marrow 6 h after ischemia ( Fig. 3a,b ), which reflected the release of myeloid cells after brain injury. Notably, in the tibia, the cell number did not decrease significantly ( Fig. 3a,c) . Likewise, the vertebral marrow did not show a major reduction of myeloid cells 6 h after stroke ( Supplementary Fig. 5 ). When normalized to sham controls, the poststroke skull marrow contained significantly fewer neutrophils and monocytes than the tibia (Fig. 3d,e ). Viewed together with the higher cell traffic from the skull ( Fig. 2a ), these data indicate that after stroke, the skull marrow released myeloid cells more vigorously than the tibia. Comparing naive skull and tibial neutrophils in vitro, we found no difference in the cells' migration through activated brain endothelium ( Supplementary Fig. 6 ). To begin deciphering the mechanisms behind the observed marrow heterogeneities, we compared SDF-1 levels between the skull and tibial marrow by enzyme-linked immunosorbent assay (ELISA). SDF-1 retains leukocytes in hematopoietic niches, and its decrease leads to monocyte and neutrophil release from the marrow 11 . SDF-1 production increases in the brain after stroke 12 . Six hours after stroke, we observed a significant decline in SDF-1 levels in the skull only ( Fig. 4a ), which may have contributed to a preferential release of neutrophil from this site. Since bone marrow vascular permeability may regulate leukocyte release, we assessed this parameter using an Evans Blue assay 9 . Six hours after stroke, vascular permeability did not change significantly in either skull or tibia (Fig. 4b,c ). A trend toward higher permeability of the skull marrow, after cisternal carrageenan injection, and a decrease in tibial marrow permeability were observed ( Fig. 4d ). Thus, regional heterogeneities in the leukocyte retention factor SDF-1 and vascular permeability may contribute to the preferred mobilization of skull neutrophils in the context of brain inflammation.
Direct vascular channels connect skull marrow and the CNS surface.
Since the skull provides more neutrophils to acutely inflamed brain tissue than remote tibial marrow, we tested the hypothesis that this is due to the proximity of the skull marrow to the brain. We reasoned that direct vascular connections could provide either a conduit Supplementary Fig. 2 . b, Neutrophil and monocyte numbers in skull after stroke or sham controls (neutrophils: n = 16 mice for stroke, n = 17 mice for sham, 6 experiments; Ly6C hi monocytes, n = 13 mice for stroke, n = 12 mice for sham, 4 experiments; two-tailed Mann-Whitney test, neutrophils, **P = 0.008; monocytes, **P = 0.007). c, Neutrophil and monocyte numbers in both tibiae (neutrophils, n = 16 mice for stroke, n = 17 mice for sham, 6 experiments; Ly6C hi monocytes, n = 13 mice for stroke, n = 12 mice for sham, 4 experiments; two-tailed Mann-Whitney test, neutrophils, P = 0.49; monocytes, P = 0.54). d,e, Data normalized to sham at 6 h (neutrophils, n = 16 mice per condition; monocytes, n = 12 mice; 4 experiments) and 3 d after stroke (n = 7 mice per condition, 3 experiments; two-tailed paired Wilcoxon test; neutrophils: 6 h, **P = 0.002, skull vs. tibia; 3 d, *P = 0.031, skull vs. tibia; monocytes: 6 h, *P = 0.016, skull vs. tibia; 3 d,*P = 0.016, skull vs. tibia). See Supplementary Fig. 5 for spine; ns, nonsignificant.
for danger signals that alert the skull marrow of CNS inflammation or a path for leukocytes that migrate toward the brain. When studying the skull-brain intersection by confocal microcopy on coronal views, we observed a number of channels that connect marrow cavities with the dura mater through the skull's inner cortex (Fig. 5 ). The channels were surrounded by Osteosense signal (Fig. 5a ), which arose from osteoblasts lining the bone surface 13 . Inside these channels, we detected fluorescent signal for CD31, indicating endothelial lining, Cx3cr1 GFP -positive monocytes and Ly6G + neutrophils ( Fig. 5a -c). To image the inside of the skull's surface, we immersed freshly harvested skull in an organ bath, with the interior surface facing the microscope's objective ( Fig. 5b ). In this orientation, we likewise observed numerous channels traversing the inner cortical layer of the skull bone. This experimental setup provided the opportunity to acquire z-stacks and time-lapse data ( Fig. 5d,e ). Notably, we frequently observed Ly6G + neutrophils migrating through channels, ultimately emerging at the inner skull surface (Supplementary Video 1). To determine whether there is cell traffic in these channels in vivo, we next imaged 4-week-old mice. Young mice have thinner skulls, which allowed us to image the inner skull bone layers in vivo. In these mice, we observed that blood flow through channels was directed toward the marrow cavities. However, neutrophils traveled against the flow, toward the dura mater, after induction of stroke ( Fig. 5f and Supplementary Videos 2 and 3). Neutrophils exited channels more frequently in skulls harvested from mice with brain inflammation after stroke or intracisternal carrageenan injection ( Fig. 6a -c and Supplementary Videos 4 and 5).
In adult mice, the channels were 21.6 ± 0.9 µ m in diameter ( Fig. 6d ). Electron microscopy confirmed the channels' endothelial lining and showed that the channel lumen connects with vasculature in the dura mater ( Fig. 7a-d ). After stroke, neutrophils exited blood vessels in the dura ( Supplementary Fig. 7 ). High resolution ex vivo X-ray computed tomography (microCT) revealed the channels' wide distribution throughout the inner and outer murine skull cortices ( Fig. 8a-e and Supplementary Video 6). Measured by microCT, the channels were similar in size in the inner and outer skull cortex ( Fig. 8f ). Compared to the histology data, the average channel diameter was slightly lower on microCT, which we attribute to partial volume effects and the lower resolution of the X-ray based modality. In the tibia, we observed similar channels traversing the bone cortex ( Fig. 8f ).
Finally, we explored whether such channels exist in humans. To this end, we imaged craniectomy specimens obtained during decompression surgery in 3 patients (clinical information is provided in the Methods). In all three samples, we identified similar channels (albeit with 5.3-fold larger mean diameters) connecting the inner skull cortex surface with marrow cavities (Fig. 8g-k) . In contrast to mice, channels through the human outer skull cortex were larger than channels traversing the inner skull cortex (Fig. 8l ).
In the interior human skull cortex, the channels occupied 2.5 ± 0.2% of the bone volume.
Discussion
We here apply a method for tracking cell origins from different bone marrow locations to study inflammation in several organs. When inflammation occurred in the brain, the organ had a high propensity to recruit neutrophils from skull bone marrow. We detected this recruitment bias by flow cytometry after tagging cells in the marrow. No such preference was present when inflammation befell the heart, suggesting that anatomic proximity could be instrumental for leukocyte migration in general and specifically for inflammatory brain disorders. Confocal microscopy on the inside of the skull after stroke or intracisternal carrageenan injection revealed myeloid cell traffic through small vascular channels that connect the skull marrow with the meninges. These data challenge the current dogma that after any inflammatory stimulus, the marrow homogeneously releases leukocytes into the systemic circulation, followed by cell recruitment into the injured site from the blood pool. The meninges carry a rich vascular network that originates from the cerebral arteries, external carotid arteries, and the diploic veins.
Diploic veins connect the pericranial and endocranial venous system through the skull 14, 15 . On the brain surface, meningeal vessels can expand through the arachnoid layer, which provides access to the cerebrospinal fluid 14 . Diploic vessels pass through the human cranium mostly in the parietal bone 16 . Those vessels average 1.5 mm in diameter, but diploic veins also connect to a microscopic network of venous channels 14, 17 . Specifically, human corrosion casts display numerous microvessels branching toward the marrow cavity 14 . Our microCT data indicate that there are direct connections between skull marrow cavities and the inner surface of the skull bone in mice and humans. Whether leukocytes frequent these channels in humans, in parallel to our in vivo microscopy observations in mice, is currently unclear.
In the setting of brain inflammation, vascular structures may be damaged or become leaky. Such pathologies, our data indicate, could trigger direct skull marrow supply of inflammatory cells to the surface of the brain. After stroke, we observed leukocytes moving through channels against the blood flow toward the dura, as well as extravasated neutrophils in the dura, which supports the idea that skull-derived neutrophils may migrate directly to the brain. Other cell types or pathogens may travel the same way. Notably, meninges emerge as a site of early inflammatory processes in chronic neurological diseases such as multiple sclerosis 18 . Innate immune cells, particularly neutrophils and monocytes, are also being studied in the setting of Alzheimer's disease [19] [20] [21] .
Skull neutrophil supply could thus contribute to chronic neurodegenerative disorders like Alzheimer's, as neutrophils are observed at the cerebromeningeal level early in the course of the disease 21 .
Trauma to the skull may also impact the dynamics and supply of inflammatory cells to the meninges and the brain, possibly affecting inflammatory activity in the CNS. Because the channels are not a one-way street, signaling molecules originating from the inflamed brain may preferentially reach the skull marrow. This could trigger local alteration of the hematopoietic stem cell niche, as indicated by our data on SDF-1, and perhaps also condition leukocytes and their progenitors. As a consequence, skull neutrophils may be more inflammatory, more numerous, and more prone to interact with brain macrophages, in particular at the perivascular level [22] [23] [24] . Altogether, such local interactions may explain the preferential skull neutrophil recruitment we observed in the inflamed brain and may initiate neuroinflammatory cascades.
Leukocyte access to ischemic brain may rely on alternate migratory paths independent of the systemic circulation, a speculation that agrees with our observation of bias toward skull marrow recruitment in CNS inflammation. We observed leukocytes in perivascular spaces of the dura after stroke induction, similarly to prior findings in rodents and humans that stressed the importance of the leptomeningeal vessels for leukocyte migration into inflamed brain tissue 25, 26 . Though this study was limited by the small number of cells available for histological analysis, we still found that skull neutrophils were more numerous at the brain surface than cells originating from the tibia, which suggests that leptomeningeal vessels may enrich for leukocytes originating from the skull marrow.
The dura is composed of thick collagen layers and contains arterial, venous, and lymphatic components 27 . Dural lymphatic vessels may carry immune cells from the CNS to the periphery 28,29 . However, lymphatic drainage is absent from bone marrow, and the channel microanatomy is not suggestive of lymphatic endothelium. Whether leukocytes extravasated in the dura enter the lymphatic system or the brain parenchyma requires further investigation. In steady state, an impervious barrier separates the dura from the leptomeninges 27 . This may change in inflammatory conditions. Direct leukocyte migration through these layers could represent an alternative migratory path, particularly in the context of severe stroke or meningitis that triggers inflammation on the brain's surface. Proteases released from activated mast cells and macrophages in the dura may loosen the extracellular matrix, thus facilitating cell migration [30] [31] [32] .
Our work focused on early inflammatory events and neutrophil migration, cells considered to be first responders to infection and injury. In the setting of sterile inflammation, neutrophils are destructive, as their defensive weaponry inflicts damage on the organ stroma 33 . In ischemic stroke, and particularly after reperfusion, neutrophils contribute to blood-brain barrier disruption, edema, oxidative stress, protease activity, neuronal death, infarct expansion, and poor neurological outcomes 2, 34 . Neutrophils are among the cells with the shortest lifespans; therefore, the study of their production and migration provides insight into mechanisms that bring about the population increase seen in inflamed tissue.
This work poses several questions. The channels' function in humans is currently unknown, but it would be valuable to estimate the contribution of this migratory path in steady state and during chronic and acute brain inflammation. It would be of interest to explore whether and how the blood flow and cell migration through these channels is regulated and how it changes with increased intracranial pressure. An additional putative channel function is information transfer, as soluble inflammatory factors, including danger-associated molecular patterns arising from ischemic brain, may alert the skull marrow 6 . Finally, it will be of interest to study whether inhibition of cell migration through the described channels has anti-inflammatory effects. 
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41565-018-0195-y. immunology, and clearance of waste from the brain. Prog. Neurobiol. 156, 107-148 (2017 
Animals and experimental parameters. We used 4-week-old and 3-month-old male C57BL/6 mice from Jackson Laboratories, and bred heterozygous Cx3cr1 GFP (3-to 6-month-old males were used in experiments). All the procedures were performed in accordance with the ARRIVE guidelines and the Guide for Care and Use of Laboratory Animals (NIH Publication No. 85- 23, 1996) , and have been approved by the institutional review board (MGH Subcommittee on Research Animal Care). Mice were randomly distributed to experimental groups. As the same experimenter performed the surgeries, organ and sample harvesting, and sample preparation for flow cytometry, blinding was not implemented.
Human samples. The Institutional Review Board of Dongguk University at the Ilsan Hospital approved this study. All patients or their legally authorized representatives gave written informed consent. We imaged skull specimens obtained from two males (52 and 33 year old) and one female (53 years old). The 52-year-old male had decompression surgery 2 d after bilateral ischemic stroke, and his comorbidities were hyperlipidemia, hypertension, and diabetes mellitus. The other male had decompression surgery after trauma. The female patient underwent retromastoid craniotomy for microvascular decompression surgery.
Bone marrow tagging by microinjection technique.
Deep red CellTracker (C34565 Molecular Probes) and CMFDA (green) CellTracker (C7025 Molecular Probes) dyes were prepared fresh before each experiment by dissolving them in 3 µ L DMSO (D8418 Sigma) and then adding 297 µ L sterile saline. Microinjection of the tibia and skull marrow were performed sequentially under 1.5% isoflurane anesthesia, using a 5-µ L syringe (#65 Hamilton Co, Reno, NV USA) mounted with a custom 34-gauge blunt needle (RN 0.375" PT3). Aseptic technique was used for each procedure. The skin above the skull was opened at the midline to expose both anterior (near bregma) and posterior (beside the cerebellum) marrow sites. One or two microinjections were performed for each marrow site (right frontal, left frontal, and occipital). First, 'predrilling' was done using a 30-gauge needle (ref #305106 BD) with great care to prevent perforation of the inner wall of the skull. Animals with unsuccessful procedures at this stage were removed from the study. A total volume of about 2-3 µ L of the red tracker was slowly injected per injection site through the predrilled spots (20-30 s per injection), for a total of 10 µ L of red tracker injected per skull (4 injection sites). The injection was monitored through the microscope. Thereafter, the skin was sutured with 6-0 silk. The skull was kept moist throughout the procedure using sterile saline. For the tibia marrow injection, disinfected skin was opened just below the knee and the muscle insertion locally scrapped off the bone at the chosen injection site. The bone wall was perforated with a 30-gauge needle (ref # 305106 BD). The needle of the Hamilton syringe was introduced into the marrow cavity to inject 3 µ L of the green cell tracker over 30 s. The skin was sutured with 6-0 thread. Animals were killed for analysis 6-48 h after injection, followed by cardiac perfusion with 20 mL of PBS.
Stroke induction.
Stroke was induced using a filament MCAO (middle cerebral artery occlusion) model under anesthesia (1.5% isoflurane) and using a temperature-control system (Harvard apparatus, Holliston, MA USA). Mice were given preemptive analgesia (buprenorphine 0.1 mg/kg SC) and follow-up doses until they were killed for analysis. Briefly, the right carotid bifurcation was accessed through cervicotomy and careful dissection. After permanent ligation of the external carotid artery (ECA), a silicon coated 7-0 filament (Doccol corporation, Sharon, MA USA) was introduced from the ECA to the internal carotid artery until block. The filament was left in place either permanently or for 30 min and then pulled out to achieve reperfusion. Success of the procedure was monitored by the presence of a brain cortical pallor/edema at death, or the presence of neurological signs on basic mouse examination (circling behavior, impaired forelimb flexion associated with clasping reflex). Corresponding sham surgery comprised skinopening, dissection of the carotid bifurcation, and ligation of the right external carotid artery.
Carrageenan injection. For intracisternal (IC) injections, pre-emptive buprenorphine (Buprenex) was given subcutaneously (0.1 mg/kg). Lambda carrageenan was bought from Sigma (#22049). To induce aseptic meningoencephalitis, we adapted a published protocol 10 and injected 5 µ L of 0.5% carrageenan (w/V) diluted in sterile saline in the cisterna magna, during 1.5% isoflurane anesthesia. The mouse was installed on a stereotactic frame (Stoelting, Wood dale IL USA). After shaving, disinfection, opening of the skin, and dissection of the cervical muscles, the cisterna magna membrane was visualized under microscopy and punctured using a Hamilton syringe (Gastight #1701) mounted with a 34-gauge needle. Carrageenan was injected slowly over 1 min. Excess carrageenan was removed with a cotton swab. The skin was then sutured and the mouse allowed to recover. Corresponding sham surgery consisted of skin opening and dissection of the cervical muscles only.
Myocardial infarction.
Under isoflurane anesthesia, the mouse was intubated and ventilated (Inspira, Harvard Apparatus). A thoracotomy was then performed between the third and fourth ribs to visualize the heart. After removing the connective tissue, an 8-0 suture was placed to ligate the left coronary artery.
The rib cage was then closed with two separate 5-0 sutures, a 20-gauge sheath left between the sutures, and the dermis glued shut with surgical glue. Finally, air was removed from the thoracic cavity via the sheath and a 3-mL syringe before the animal was extubated.
Confocal microscopy. Microscopy of the skull, tibia, or brain was performed with a confocal microscope (IV100 Olympus). Field of view at 4 × magnification covers 2,290 µ m by 2,290 µ m, and at 20 × covers 458 µ m by 458 µ m with a resolution of 512 by 512 pixels. For video acquisition, time-lapse was either 1.64 or 4.89 s per image. Images were reconstructed using Imaris software (Bitplane, Zurich, Switzerland) or Matlab. For in vivo imaging, we used a customized Olympus FV1000 BX61-W1 (Olympus America) confocal/multiphoton microscope. A 20 × water-immersion objective with a high numerical aperture (NA) and large working distance (Olympus, XLUMPLFLN 1 NA, 2-mm wd) were used for imaging. Images 256 × 256 in size and with 4 µ s/pixel integration time were acquired in confocal modality.
Histology. After the mice were killed with cardiac perfusion of 20 mL PBS, brains were frozen at -35 °C in 2-methyl-butane and further sectioned at 50 µ m on a cryostat (CM 3050 S, Leica, Wetzlar, Germany). After postfixation in 4% paraformaldehyde, the sections were imaged on a microscope (Eclipse TE2000-U Nikon).
Electron microscopy. Tissues were fixed by cardiac perfusion with formaldehyde/ glutaraldehyde (2.5% each) followed by postfixation overnight in the same fixative. Calvaria were decalcified with 4.13% EDTA and 0.44% NaOH in distilled water (pH 7.3) at 4 °C with solution changed every 2 d for at least 2 weeks. The samples were then washed in 0.1 M cacodylate buffer and postfixed with 1% osmium tetroxide (OsO 4 )/1.5% potassium-ferrocyanide (KFeCN 6 ) for 1 h, washed in water 3 times, and incubated in 1% aqueous uranyl acetate for 1 h, followed by two washes in water and then dehydration in ethanol. The samples were then put in propylene oxide for 1 h and incubated overnight in a 1:1 mixture of propylene oxide and TAAB Epon (Marivac Canada Inc. St. Laurent, Canada). The following day the samples were embedded in TAAB Epon and polymerized at 60 °C for 48 h. Ultrathin 80-nm-thick sections were cut on a Reichert Ultracut-S microtome, placed on copper grids, stained with lead citrate, and examined in a JEOL 1200EX transmission electron microscope. Images were recorded with an AMT 2k CCD camera.
Ex vivo microscopy of the skull and the tibia. To identify bone, animals were injected with Osteosense 750EX (4 nmol/mouse, PerkinElmer) the day before imaging. The vasculature was labeled in vivo with 50 µ L of RPE anti-mouse CD31 antibody (#553373, BD Biosciences) or isolectin B4 (FL-1201, Vector Labs), injected IV 1 h before the mouse was killed. Mice were killed 2 h after either skull or tibia microinjection by perfusion with 20 mL of PBS or 7 h after systemic injection of Evans Blue 3% (w/vol in sterile saline). The skull and tibiae were dissected and cleaned before fixation for 1 h in 4% paraformaldehyde in PBS, then rinsed twice in PBS for 10 min. Tibiae were then embedded in Tissue-Tek O.C.T (#4583, Sakura Finetek Inc., Torrance, CA, USA) on dry ice and kept at -20 °C. They were later shaved on a cryostat (CM 3050 S, Leica, Wetzlar, Germany) to expose the bone marrow compartment. Z-stack images were acquired with 2-µ m steps at 20 × magnification. Images were processed using Imaris (Bitplane, Zurich, Switzerland). Maps of the entire bones for the injection sites were generated by stitching together multiple images acquired at 4 × magnification, using the Affinity Designer software (Serif, Nottingham, UK). Sizes of the channels were determined manually using the measuring distance tool in Imaris (Bitplane, Zurich, Switzerland).
Skull marrow organ bath. To explore cell traffic through the skull channels to the meninges, we employed an organ bath system. After in vivo staining of the bone surface with Osteosense 750EX (4 nmol/mouse, PerkinElmer) the day before the experiment, the vasculature and neutrophils were stained with IV injections of 50 µ L of RPE anti-mouse CD31 (#553373, BD Biosciences) and 50 µ L of APC anti-mouse Ly6G (#127614, Biolegends) antibodies 1 h before the mice were killed. Using surgical scissors, we obtained a skull piece of about 4 by 4 mm, respecting the integrity of the dura and the visible edges of the marrow cavities. This specimen was flipped upside down and rapidly transferred into the organ bath. The specimen was placed on a stage and immersed in a solution of 50 µ mol fMLP (F3506 Sigma-Aldrich), used as chemoattractant, in HBSS. This protocol was adopted from previously published in vitro neutrophil migration assays 35 . The organ bath was maintained at 37 °C by a warming plate (ATC-2000 World Precision Instruments). The same conditions were implemented to explore neutrophil migration through the channels 4-6 h after permanent MCAO or after intracisternal injection of carrageenan, and corresponding sham or naive controls. Neutrophils exiting the channels were identified and counted using Imaris (Bitplane).
Flow cytometry.
To study the skull bone marrow, the entire calvarium and the sphenoid bone were harvested. The dura was removed using a microscope. Cell suspension was prepared by mincing the calvarium and sphenoid for 2.5 min in buffer (2.5% albumin in PBS). The obtained suspension was then filtered through a 40-µ m cell strainer into a 50-mL Falcon tube. The marrow from long bones was collected by flushing. Spine bone marrow was obtained by crushing. Marrow from sternum and pelvis bones was also obtained by crushing. Enumeration of bone marrow cellularity for all bones in naive mice relied on bones prepared by crushing only. After centrifugation at 340 g for 7 min at 4 °C, samples were resuspended in 300 µ L of buffer and kept at 4 °C until staining. Either one (stroke hemisphere) or both hemispheres (carrageenan) were collected and weighted for analysis 36 . Samples were digested for 20 min at 37 °C in 5 mL of HBSS containing 10% fetal bovine serum (#16140071, Gibco) and 1% (w/V) collagenase (#C5138, Sigma). After homogenization, samples were passed through a 40-µ m mesh cell strainer to a 50-mL Falcon tube. The suspension was completed to 30 mL with PBS and centrifuged at 450 g for 5 min. The remaining pellet was suspended in 10.5 mL of PBS and gently homogenized with 4.5 mL of isotonic Percoll (GE Healthcare). The myeloid layer was collected by aspiration after 35 min of centrifugation (900 g) with no brake at 4 °C. The Percoll was then washed off and cells were finally resuspended in 300 µ L of PBS after a last centrifugation (450 g, 5 min). Hearts were digested using a mixture of collagenase I (450 U/mL, #C0130 Sigma), collagenase XI (125 U/mL, #C7657 Sigma), hyaluronidase (60 U/mL, #H3605 Sigma), DNAse I (60 U/mL, #D5319, Sigma), and HEPES buffer (20 µ M) in PBS at 37 °C for 1 h under gentle shaking at 750 rpm. After homogenization, the preparation was filtered, washed off in buffer, spun, and resuspended in PBS. Blood was collected by retro-orbital bleeding under anesthesia at the time the mice were killed. Spleens were immediately mashed through a 40-µ m mesh on top of a 50-mL Falcon tube and suspended in 15-20 mL of buffer. After a first centrifugation (340 g, 7 min, 4 °C), hypotonic red blood cell (RBC) lysis was performed for both the blood and the spleen (#420301, Biolegends). Samples were centrifuged again (340 g, 7 min, 4 °C) before resuspension in 300 µ L (blood) or 1 mL (spleen) FACS buffer (PBS with 0.5% bovine serum albumin). The total number of cells per sample was determined using a hemocytometer and Trypan Blue staining for cell viability (Cellgro, Mediatech Inc., VA, USA). For cellularity in all bone marrow compartments in naive mice, automated cell counting was used (Countess, ThermoFisher). Leucocyte staining was performed at 4 °C for 20 min, using a combination of antibodies at a concentration of 1:300. Viability was assessed using a live/dead dye (L-34966, Life Technologies). After staining samples, were fixed (BD Cytofix, 10 min on ice). The list of antibodies used for the experiments is provided in Supplementary Table 1 .
Samples were recorded on a LSRII Flow Cytometer (BD) and data were analyzed with FlowJo software (Tree Star). Cell numbers per sample were calculated as total cells per sample multiplied by the percentage of live cells obtained from the appropriate flow cytometry gate. After gating out the lineagepositive cells (Ter119, c-kit, CD11c, CD3, CD90, NK 1.1, CD31, and B220), mature myeloid cells were identified as CD45 + and CD11B + . Subpopulations of myeloid cells were defined as follows: neutrophils (Ly6G + and CD115 -), Ly6Chi monocytes (CD115 + Ly6C + ), and microglia (Ly6Gand Ly6C -).
For the experiments involving bone marrow tagging, Deep red CellTracker and CMFDA (green) CellTracker were analyzed in the APC and FITC channels according to the excitation/emission peaks provided by the manufacturer (492/517 nm and 630/660 nm, respectively). The neutrophil population was analyzed for the presence of cells positive for the trackers at high fluorescence intensity. To take into account both potential autofluorescence and unspecific staining by the dyes at lower fluorescence intensity from circulation, the gate position for each cell tracker was based on animals that were injected IV with the same dose.
In vitro fluorescence assay for red and green trackers. Deep red CellTracker (C34565, Molecular Probes) and CMFDA (green) CellTracker (C7025, Molecular Probes) dyes were prepared fresh by dissolution in 3 µ L DMSO (D8418 Sigma) in 297 µ L FACS buffer (PBS with 0.5% bovine serum albumin) or serum (FBS #16140071, Gibco). A cell suspension was obtained from flushed tibiae as described above. A total of 700,000 cells were incubated with either the green or the red cell tracker at different concentration levels for 15 min at room temperature (20-25 °C) . Cells were then washed and resuspended in FACS buffer for flow cytometry.
Measurement of SDF-1 in bone marrow serum by ELISA.
Murine SDF-1 was quantified by an ELISA kit (DY460 Duoset). Tibial (sectioned in half) and skull (minced in PBS) marrow serum was obtained after centrifugation in a custommade two-compartment system (11, 750 g, 3 min) . The supernatant was used as indicated by the manufacturer's instructions.
In vivo bone marrow permeability to Evans Blue dye. The protocol was adapted from Itkin et al. 9 . Evans Blue 3% (w/vol in sterile saline) was injected via the jugular vein at the time of reperfusion in stroke mice (30-min occlusion time) or immediately after intracisternal injection of carrageenan at a dose of 0.07 mg/g of body weight. The entire calvarium, the sphenoid bone, and both tibia were harvested. The periosteum and dura attached to the skull samples were removed under microscopy. The pieces were then minced in 200 µ L formamide for 2 min. The tibiae were individually spun dry in a custom-made two-compartment system at 11,750 g for 3 min to recover all marrow, which was homogenized in 200 µ L formamide by vortexing. Evans Blue extraction was realized overnight at 60 °C and 700-rpm shaking. After centrifugation at 2,000 g for 30 min, 50 µ L of the supernatant was plated and read for absorbance by dual-wavelength spectrophotometric analysis at 620 nm and 740 nm (Tecan, Switzerland). Standards were prepared with Evans Blue diluted in formamide (0 to 250 µ g/mL). Absorbance was corrected for potential hematic contamination, as previously published 9 , using the formula: corrected absorbance at 620 nm = actual absorbance at 620 nm -(1.426 × (absorbance at 740 nm) + 0.03). Values were then subtracted for blank and Evans Blue amount calculated from the standards.
Mouse neutrophil transmigration assay. Mouse brain endothelial cells (MBEC) were obtained from Cell Biologics (C57-6023) and cultured on polyethylene collagen-coated membranes (8-µ m pore size; Falcon, 353182) in supplemented EBM-2 media (Lonza) until confluence. Neutrophils were isolated from skull and tibia bone marrow on MACS columns after staining with the manufacturer's antibody mix (negative selection, Miltenyi, 130097658) from 6 wild-type 3-month-old C57BL/6 mice. Cells originating from skull and tibia from the same mouse were loaded with red (skull) and green (tibia) cell-trackers, respectively, for 3 animals, and green (skull) and red (tibia) cell-trackers for the 3 others, in accordance with manufacturer's instructions (deep red CellTracker, C34565, Molecular Probes; and CMFDA (green) CellTracker, C7025, Molecular Probes). Cells were counted to obtain a cell suspension of 50% skull and 50% tibial origin.
Prior to the transmigration assay, MBECs were activated with TNFα (10 ng/mL) for 8 h and then washed. Neutrophil attractant fMLP was used at a concentration of 50 µ mol to facilitate migration toward the bottom part of the well. Finally, cells (200,000 from each compartment) were deposited on the upper part of the transwell. After 2 h, the number of cells that had migrated through the membrane was counted manually, and the composition of the population assessed by flow cytometry. The percentage of migrated cell was calculated as follows: (migrated number of cells)/(initial number of cells above the membrane).
High-resolution X-ray computed tomography. Calvaria and sphenoid bone were dissected in a naive 3-month-old C57BL/6 mouse after it was killed for analysis. Ex vivo human occipital bone, mouse frontal bone, and mouse tibial samples were scanned on a high-resolution CT scanner (µ CT40, Scanco Medical AG, Brüttisellen, Switzerland). Data were acquired using a 6-µ m 3 isotropic voxel size, 70-kVp peak X-ray tube intensity, 114-µ A X-ray tube current, and 200-ms integration time, and they were subjected to Gaussian filtration. Images were generated with Horos (https://www.horosproject.org) and Osirix (Pixmeo, Bernex, Switzerland). Image renderings were performed in Amira (FEI, Hillsboro, OR).
The human skull samples were imaged, as previously reported 37 , using microCT (mCT, NFR Polaris-G90; NanoFocusRay, Jeonju, Korea): 65 kVp, 60 μ A, 500 ms per frame, 360 views, 512 × 512 reconstruction matrix, 600 slices. The data were converted to the Digital Imaging and Communications in Medicine format (Lucion; MeviSYS, Seoul, Korea).
The human and mouse skull bone CTs were segmented by thresholding using Amira. Channel size was determined by segmenting voxels that were 3 s.d. below the mean table Hounsfield units. Channel diameters were manually determined by measuring the maximum diameter of individual channels below a Hounsfield threshold, which was 3 s.d. below that of the cortical bone's mean. Mouse tibiae were analyzed in similar fashion by removing the trabecular bone to isolate the cortical bone of an 0.15-cm axial section along the tibial crest. 3D image visualization was performed in Amira.
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Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists may be useful.
Software and code
Policy information about availability of computer code Data collection Imaris (version 7.7.2) or Matlab (version R2015a) softwares were use to reconstruct images. Affinity designer (version 1.6.1) software was used to stich 4X images for microscopy. MicroCT images were generated with Horos (version 1.1.7, https://www.horosproject.org) and Osirix software (version 3.8.1). MicroCT image renderings were performed in the Amira software (version 5.3) environment. FlowJo software (version X 10.0.7r2) was use to generate flow cytometry dotplots.
Data analysis
Imaris software (version 7.7.2) was used to analyze images. FlowJo sofware (X 10.0.7r2) was used to anayze flow cytometry data. Statistical analyses were performed using Graphpad Prism 7 software.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information. 
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Population characteristics
Three patients that underwent cranial surgery were consented to provide a specimen. These were the three first available skull specimen available during the revision period.
Recruitment
The first three consecutively available patients undergoing craniotomy, that consented to participate, were recruited to investigate if skull channels are present in humans. There were no exclusion criteria.
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Methodology
Sample preparation
Brain and tissue samples from mice were prepared by digestion, washing and staining as previously described and as listed in the method section. 
Instrument
Gating strategy
The entire gating strategy is reported in supplemental data, and the appropriate staining controls for proper gate placements.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
